COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,899 Articles (22,568 medRxiv, 8,331 bioRxiv)

Most recent first Previous |  Page 2590: Articles 25891-25900  | Next

Plasma from recovered COVID19 subjects inhibits spike protein binding to ACE2 in a microsphere-based inhibition assay
Gniffke, E. P., Harrington, W. E., Dambrauskas, N., Jiang, Y., Trakhimets, O., Vigdorovich, V., Frenkel, L., Sather, D. N., Smith, S. E. P.
10.1101/2020.06.09.20127050 — Posted: 2020-06-11
Antibody response to infectious diseases and other factors accurately predict COVID-19 infection and severity risk 10-14 years later: a retrospective UK Biobank cohort study
Willette, A. A., Willette, S. A., Wang, Q., Pappas, C., Klinedinst, B. S., Le, S., Larsen, B., Pollpeter, A., Brenner, N., Waterboer, T.
10.1101/2020.06.09.20127092 — Posted: 2020-06-11
IgA dominates the early neutralizing antibody response to SARS-CoV-2
Sterlin, D., Mathian, A., Miyara, M., Mohr, A., Anna, F., Claer, L., Quentric, P., Fadlallah, J., Ghillani, P., Gunn, C., Hockett, R., Mudumba, S., Guihot, A., Luyt, C.-E., Mayaux, J., Beurton, A., Fourati, S., Lacorte, J.-M., Yssel, H., Parizot, C., Dorgham, K., Charneau, P., Amoura, Z., Gorochov, G.
10.1101/2020.06.10.20126532 — Posted: 2020-06-11 Discussion: Onsite | Offsite
Assessment of Experiences of Preventive Measures Practice including Vaccination History and Health Education among Umrah Pilgrims in Saudi Arabia, 1440H-2019
Tobaiqy, M., Almudarra, S. S., Shams, M. M., Amer, S. A., Alcattan, M. F., Alhasan, A. H.
10.1101/2020.06.09.20126581 — Posted: 2020-06-11
Identification of SARS-CoV-2 in wastewater in Japan by multiple molecular assays-implication for wastewater-based epidemiology (WBE)
Hata, A., Honda, R., Hara-Yamamura, H., Meuchi, Y.
10.1101/2020.06.09.20126417 — Posted: 2020-06-11 Discussion: Onsite
COVID-19 infections and outcomes in patients with multiple myeloma in New York City: a cohort study from five academic centers
Hultcrantz, M., Richter, J., Rosenbaum, C., Patel, D., Smith, E., Korde, N., Lu, S., Mailankody, S., Shah, U., Lesokhin, A., Hassoun, H., Tan, C., Maura, F., Derkach, A., Diamond, B., Rossi, A., Pearse, R. N., Madduri, D., Chari, A., Kaminetzky, D., Braunstein, M., Gordillo, C., Davies, F., Jagannath, S., Niesvizky, R., Lentzsch, S., Morgan, G., Landgren, O.
10.1101/2020.06.09.20126516 — Posted: 2020-06-11 Discussion: Onsite
Mathematical estimation of COVID-19 prevalence in Latin America
Matabuena, M., Rodriguez Mier, P., Meijide-Garcia, C., Leboran, V., Gude, F.
10.1101/2020.06.09.20126326 — Posted: 2020-06-11
TMPRSS2 variants and their susceptibility to COVID-19: focus in East Asian and European populations.
Santos, N. P. C., Khayat, A. S., Rodrigues, J. C. G., Pinto, P. C., Araujo, G. S., Pastana, L. F., Medeiros, J. A. G., Fernandes, M. R., Ribeiro dos Santos, A., Khayat, B. C. M., Moreira, F. C., Ribeiro dos Santos, A. M., Assumpcao, P. B., Ribeiro dos Santos, A., Assumpcao, P. P., Santos, S.
10.1101/2020.06.09.20126680 — Posted: 2020-06-11
Work-related and Personal Factors Associated with Mental Well-being during COVID-19 Response: A Survey of Health Care and Other Workers
Evanoff, B. A., Strickland, J. R., Dale, A. M., Hayibor, L., Page, E., Duncan, J. G., Kannampallil, T., Gray, D. L.
10.1101/2020.06.09.20126722 — Posted: 2020-06-11
Knowledge, attitudes, and practices among the general population during COVID-19 outbreak in Iran: A national cross-sectional survey
Kakemam, E., Ghoddoosi-Nejad, D., Chegini, Z., Momeni, K., Salehinia, H., Hassanipour, S., Ameri, H., Arab-Zozani, M.
10.1101/2020.06.10.20127258 — Posted: 2020-06-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).